Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Paclitaxel or its derivativesPDL I DEC / 13
Palbociclib or its saltsPDL I AUG / 16
PaliferminPDL I DEC / 13
Paliperidone or its salts or its derivativesPDL I DEC / 13
PalivizumabPDL I DEC / 13
Palonosetron or its saltsPDL

including but not limited to palonosetron hydrochloride

I DEC / 13
Pamidronic acid or its saltsPDL I DEC / 13
Pancreatic extractsPDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
PancreatinPDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
PancrelipasePDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancuronium or its saltsPDL I DEC / 13
PanitumumabPDL I DEC / 13
Pantoprazole or its saltsPDL I DEC / 13
Papaveretrine or its salts I SEP / 98
Papaverine or its salts I SEP / 98
ParaldehydePDL I DEC / 13
ParamethadionePDL I DEC / 13
Pargyline or its saltsPDL I DEC / 13
ParicalcitolPDL I DEC / 13
Paritaprevir (Veruprevir)PDL I MAR / 15
Paroxetine or its saltsPDL I DEC / 13
Paroxypropione II SEP / 98
Pasireotide or its saltsPDL I DEC / 13
Patiromer sorbitex calciumPDL I NOV / 18
Patisiran or its saltsPDL I JUL / 19
Pazopanib or its saltsPDL I DEC / 13
Pegaptanib or its saltsPDL I DEC / 13
PegaspargasePDL I APR / 17
PegfilgrastimPDL I DEC / 13
PegvisomantPDL I DEC / 13
PembrolizumabPDL I JUN / 15
Pemetrexed or its saltsPDL I DEC / 13
Pemoline and any salt thereofC I JAN / 03
Penciclovir or its saltsPDL I DEC / 13
PenicillaminePDL I DEC / 13
Penicillin or its salts or derivativesPDL

Including but not limited to:
Amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, nafcillin, oxacillin, ticarcillin, penicillin G (benzyl penicillin), procaine penicillin G.
 

I DEC / 18
Pentaerythritol tetranitrate I SEP / 98
Pentagastrin and its salts II SEP / 98
Pentamidine or its saltsPDL I DEC / 13
PentobarbitalC I JUN / 02
Pentolinium tartratePDL I DEC / 13
Pentosan polysulfate or its saltsPDL I DEC / 13
Pentostatin or its saltsPDL I DEC / 13
Pentoxifylline or its saltsPDL I DEC / 13
Peramivir or its salts or derivativesPDL I MAR / 17
PerampanelPDL I DEC / 13
PerflutrenPDL I DEC / 13
Pergolide or its saltsPDL I DEC / 13
Pericyazine or its saltsPDL I DEC / 13
Perindopril or its saltsPDL I DEC / 13
Permethrin and its derivatives II SEP / 98
Permethrin or its derivativesPDL

For veterinary use, when recommended in cats.

I DEC / 13
Perphenazine or its saltsPDL I DEC / 13
Pertussis vaccine II DEC / 98
PertuzumabPDL I DEC / 13
Phacetoperane or its saltsPDL I DEC / 13
PhenacemidePDL I DEC / 13
PhenacetinPDL I DEC / 13
PhenaglycodolPDL I DEC / 13
Phenalkoxams, their salts, derivatives and salts of derivativesN

Including: Dimenoxadol, Dioxaphetyl butyrate, Dextropropoxyphene 
 

I JUN / 02
Phenazepines, their salts, derivatives and salts of derivativesN

Including: Proheptazine; but not including: Ethoheptazine and its salts; Metethoheptazine and its salts; Metheptazine and its salts

I JUN / 02
Phenazopyridine or its saltsPDL I DEC / 13
Phencyclidine, its salts, derivatives and analogues and salts of derivatives and analoguesN

Including: Ketamine

I JUN / 02
Phendimetrazine and any salt thereofC I JUN / 02
Phenelzine or its saltsPDL I DEC / 13
Phenformin and its saltsPDL I DEC / 13
Pheniprazine or its saltsPDL I DEC / 13
Pheniramine U
Phenmetrazine and any salt thereofC I JUN / 02
Phenol preparations with concentration of more than 20% II SEP / 98
Phenoxybenzamine and its salts II SEP / 98
Phentermine and any salt thereofC I JUN / 02
Phenthoxate or its saltsPDL I DEC / 13
Phentolamine or its saltsPDL I DEC / 13
Phenylbutazone or its saltsPDL I DEC / 13
Phenylbutyric acid or its salts or derivativesPDL

Including but not limited to glycerol phenylbutyrate, phenylbutyrate sodium.

I AUG / 16
Phenylephrine and its salts and preparations in nasal preparations in concentrations of 2.5% or less, for pediatric use II SEP / 98
Phenylephrine and its salts and preparations. for oral use, in nasal preparations for adults and in ophthalmic preparations in concentrations of 2.5% or less U
Phenylephrine or its saltsPDL

In preparations for parenteral use or ophthalmic use in concentrations greater than 2.5%.

I DEC / 13
Phenylindanedione or its derivativesPDL I DEC / 13
Phenylpiperidines, their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analoguesN

Including: Allylprodine; Alphameprodine; Alphaprodine; Anileridine; Betameprodine; Betaprodine; Benzethidine; Diphenoxylate; Difenoxin; Etoxeridine; Furethidine;  Hydroxypethidine; Ketobemidone; Methylphenylisonipecotonitrile; Morpheridine; Norpethidine; Pethidine; Phenoperidine; Piminodine; Properidine; Trimeperidine; Pethidine Intermediate C; but not including: Carperidine and its salts; Oxpheneridine and its salts
 

I JUN / 02
Phenylpropanolamine or its salts or derivativesPDL I DEC / 13
Phenyltoloxamine and its salts III SEP / 98
Physostigmine salicylatePDL

For human use - except preparations for oral or topical use only.

I DEC / 13
Physostigmine salicylate.

for oral or topical use

II SEP / 98
Phytocannabinoids produced by, or found in, the cannabis plant and substances that are duplicates of such phytocannabinoids.*PDL

except:
1) derivatives of cannabis as defined in subsection 2(1) of the Cannabis Act that are exempt from the application of the Cannabis Act under the Industrial Hemp Regulations and that do not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, or

2) anything referred to in Schedule 2 to the Cannabis Act that contains no more than 10 µg/g delta-9-tetrahydrocannabinol and that does not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid.

*Note: this listing is copied from the Health Canada Prescription Drug List and applies to products that have received a Notice of Compliance and Drug Identification Number and been classified as prescription drugs by Health Canada. Cannabis products, as defined in the Cannabis Act and its regulations, are not granted a Notice of Compliance and Drug Identification Number by Health Canada and are considered outside the scope of the National Drug Schedules.

I OCT / 18
PibrentasvirPDL I SEP / 17
Pilocarpine or its saltsPDL I DEC / 13
PimecrolimusPDL I DEC / 13
PimobendanPDL I DEC / 13
PimozidePDL I DEC / 13
Pinaverium bromidePDL I DEC / 13
Pindolol or its saltsPDL I DEC / 13
Pioglitazone or its saltsPDL I DEC / 13
Pipecuronium bromidePDL I DEC / 13
Piperacetazine or its saltsPDL I DEC / 13
Piperazine and its salts II SEP / 98
Piperilate or its saltsPDL I DEC / 13
PipobromanPDL I DEC / 13
Pipotiazine or its saltsPDL I DEC / 13

199 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act